Home
Archive
Contact
✕
February 2023
Home
2023
February
February 10, 2023
February 10, 2023
Categories
From the Co-Chairs
From the Co-Chairs, February 2023
Plans for the year ahead; a focus on data; the future of cancer screening studies
February 10, 2023
February 10, 2023
Categories
Active Clinical Trials
Now Enrolling: EA8212/BRIDGE for Non-Muscle Invasive Bladder Cancer
This phase 3 study is comparing the efficacy of intravesical chemotherapy after surgery to the usual approach of intravesical immunotherapy after surgery
February 10, 2023
February 10, 2023
Categories
Active Clinical Trials
TMIST Passes 80,000 Patients Enrolled
Even as screening mammography volumes remain below pre-pandemic levels, TMIST continues to enroll women at a strong pace
February 10, 2023
February 10, 2023
Categories
Active Clinical Trials
Trial Spotlight: A Closer Look at ECOG-ACRIN’s Myeloma Studies
These three trials are open and enrolling adults with multiple myeloma or at high risk of developing the disease
February 10, 2023
February 10, 2023
Categories
Trial Results
Trial Results: ASH Highlights Practice-Changing Results for B-Lineage Acute Lymphoblastic Leukemia
The phase 3 E1910 clinical trial provides strong evidence for adding immunotherapy to standard front-line consolidation chemotherapy
February 10, 2023
February 10, 2023
Categories
Trial Results
Trial Results: ECOG-ACRIN Research Round-Up
Summaries of recently published ECOG-ACRIN research results
February 10, 2023
February 10, 2023
Categories
News in Brief
News in Brief, February 2023
Summaries and links to timely information about research results in medical journals, recognition of research leaders, and more